The table below shows Coherus BioSciences, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$12.31M
$11.57M
$10.25M
$7.60M
$6.05M
$10.30M
Cost of revenue
$3.81M
$3.72M
$3.40M
$2.65M
$2.73M
$1.81M
Gross profit
-
-
-
-
-
-
R&D
$21.54M
$27.25M
$26.31M
$24.36M
$22.05M
$20.60M
CHRS annual revenue (10-K history)
Coherus BioSciences, Inc. reported annual revenue of $42.17M for fiscal year 2025. That is up 59.8% from $26.39M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $190.11M (FY 2016) to $42.17M. Figures come from the company's audited annual reports as filed with the SEC.